Oaktree Acquisition Corp II (OACB) 10-Q/A 13 Dec 21 2021 Q3 Quarterly report (amended) Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Nov. 15, 2021
Document Information [Line Items]
Document Type	10-Q/A
Entity Interactive Data Current	Yes
Amendment Flag	true
Document Period End Date	Sep. 30, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Document Quarterly Report	true
Document Transition Report	false
Entity Registrant Name	Oaktree Acquisition Corp. II
Entity Central Index Key	0001820931
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	true
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Address, State or Province	CA
Entity File Number	001-39526
Entity Address, Address Line One	333 South Grand Avenue
Entity Address, Address Line Two	28th Floor
Entity Incorporation, State or Country Code	E9
Entity Address, City or Town	Los Angeles
Entity Address, Postal Zip Code	90071
City Area Code	213
Local Phone Number	830-6300
Entity Tax Identification Number	98-1551592
Amendment Description	References throughout this Amendment No. 1 to the Quarterly Report on Form 10-Q to “we,” “us,” the “Company” or “our company” are to Oaktree Acquisition Corp. II, unless the context otherwise indicates. This Amendment No. 1 (“Amendment No. 1”) to the Quarterly Report on Form 10-Q/A amends the Quarterly Report on Form 10-Q of Oaktree Acquisition Corp. II as of and for the period ended September 30, 2021, as filed with the Securities and Exchange Commission (“SEC”) on November 15, 2021. On September 21, 2020, the Company consummated its Initial Public Offering (“IPO”) of 25,000,000 Class A ordinary shares (the “Public Shares”), including the 2,500,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $250.0 million. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 4,666,667 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $7.0 million. On November 15, 2021, Oaktree Acquisition Corp. II (the “Company”) filed its Form 10-Q for the quarterly period ending September 30, 2021 (the “Q3 Form 10-Q”), which included a Note 2, Revision of Previously Issued Financial Statements, (“Note 2”) that describes a revision to the Company’s classification of its Public Shares issued in the Company’s IPO on September 21, 2020. As described in Note 2, upon its IPO, the Company classified a portion of the Public Shares as permanent equity to maintain net tangible assets greater than $5,000,000 on the basis that the Company will consummate its initial business combination only if the Company has net tangible assets of at least $5,000,001. Previously, the Company did not consider redeemable stock classified as temporary equity as part of net tangible assets. Effective with these financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. As a result, management corrected the error by restating all Public Shares as temporary equity. This resulted in an adjustment to the initial carrying value of the Class A ordinary shares subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A ordinary shares. In connection with the change in presentation for the Class A ordinary shares subject to possible redemption, the Company revised its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares. This presentation differs from the previously presented method of earnings per share, which was similar to the two-class method. The Company determined the changes were not qualitatively material to the Company’s previously issued financial statements and did not restate its financial statements. Instead, the Company revised its previously filed financial statements in Note 2 to its Q3 Form 10-Q. Although the qualitative factors that management assessed tended to support a conclusion that the misstatements were not material, these factors were not strong enough to overcome the significant quantitative errors in the financial statements. The qualitative and quantitative factors support a conclusion that the misstatements are material on a quantitative basis. Management concluded that the misstatement was such of magnitude that it is probable that the judgment of a reasonable person relying upon the financial statements would have been influenced by the inclusion or correction of the foregoing items. As such, upon further consideration of the change, the Company determined the change in classification of the Class A ordinary shares and change to its presentation of earnings per share is material quantitatively and it should restate its previously issued financial statements. Therefore, on December 2, 2021, the Company’s management and the audit committee of the Company’s board of directors (the “Audit Committee”) concluded that the Company’s previously issued (i) audited balance sheet as of September 21, 2020 (the “Post IPO Balance Sheet”), as previously revised in the Company’s Annual Report on Form 10-K, as amended, for the fiscal year ended December 31, 2020, filed with the SEC on May 19, 2021 (“2020 Form 10-K/A No. 1”), (ii) audited financial statements included in the 2020 Form 10-K/A No. 1, (iii) unaudited interim financial statements included in the Form 10-Q for the quarterly period ended September 30, 2020 as previously revised in the 2020 Form 10-K/A No. 1; (iv) unaudited interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021, filed with the SEC on May 20, 2021; (v) unaudited interim financial statements included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021, filed with the SEC on August 16, 2021, and (vi) Note 2 to the unaudited interim financial statements and Item 4 of Part 1 included in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the SEC on November 15, 2021 (collectively, the “Affected Periods”), should be restated to report all Class A ordinary shares as temporary equity (and other related changes) and should no longer be relied upon. As such, the Company will restate the unaudited interim financial statements for the quarterly periods ended March 31, 2021 and June 30, 2021 and footnote 2 to the unaudited interim financial statements and Item 4 of Part 1 included in the Q3 Form 10-Q in this Quarterly Report on Form 10-Q/A. The Company determined that none of the above changes will have any impact on its cash position and cash held in the trust account established in connection with the IPO. After re-evaluation, the Company’s management has concluded that in light of the errors described above, a material weakness existed in the Company’s internal control over financial reporting during the Affected Periods and that the Company’s disclosure controls and procedures were not effective. The Company’s remediation plan with respect to such material weakness is described in more detail in Item 4 of Part I to this Quarterly Report on Form 10-Q/A.
Common Class A [Member]
Document Information [Line Items]
Trading Symbol	OACB
Security Exchange Name	NYSE
Title of 12(b) Security	Class A ordinary share, par value $0.0001 per share
Entity Common Stock, Shares Outstanding		25,000,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		6,250,000
Capital Units [Member]
Document Information [Line Items]
Trading Symbol	OACB.U
Security Exchange Name	NYSE
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fourth of one redeemable warrant
Warrant [Member]
Document Information [Line Items]
Trading Symbol	OACB WS
Security Exchange Name	NYSE
Title of 12(b) Security	Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 918,710	$ 1,277,714
Prepaid expenses	157,607	249,389
Total current assets	1,076,317	1,527,103
Investments held in Trust Account	250,001,168	250,006,919
Total assets	251,077,485	251,534,022
Current liabilities:
Accounts payable	85,720	6,997
Accrued expenses	3,116,601	197,590
Accrued expenses—related party	210,822	57,930
Advance from related party	119,159	119,159
Total current liabilities	3,532,302	381,676
Deferred legal fees	100,000	100,000
Deferred underwriting commissions	8,750,000	8,750,000
Derivative warrant liabilities	9,825,000	21,374,160
Total liabilities	22,207,302	30,605,836
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 per share; 25,000,000 shares outstanding at September 30, 2021 and December 31, 2020, respectively	250,000,000	250,000,000
Shareholders' Equity:
Preference shares	0	0
Additional paid-in capital	0	0
Accumulated deficit	(21,130,442)	(29,072,439)
Total shareholders' equity	(21,129,817)	(29,071,814)
Total Liabilities, Class A ordinary shares subject to possible redemption, and Shareholders' Deficit	251,077,485	251,534,022
Common Class A [Member]
Current liabilities:
Class A ordinary shares subject to possible redemption, $0.0001 per share; 25,000,000 shares outstanding at September 30, 2021 and December 31, 2020, respectively	250,000,000
Shareholders' Equity:
Ordinary shares	0	0
Total shareholders' equity	0	0
Common Class B [Member]
Shareholders' Equity:
Ordinary shares	625	625
Total shareholders' equity	$ 625	$ 625

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Preferred stock par value	$ 0.0001	$ 0.0001
Preferred stock shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock shares outstanding	0	0
Common Class A [Member]
Temporary equity par or stated value per share	$ 0.0001	$ 0.0001
Temporary shares outstanding	25,000,000	25,000,000
Common stock par value	$ 0.0001	$ 0.0001
Common stock shares authorized	300,000,000	300,000,000
Common stock shares issued	25,000,000	25,000,000
Common Class B [Member]
Common stock par value	$ 0.0001	$ 0.0001
Common stock shares authorized	30,000,000	30,000,000
Common stock shares issued	6,250,000	6,250,000
Common stock, shares outstanding	6,250,000	6,250,000

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	2 Months Ended	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2021
General and administrative expenses	$ 35,631	$ 2,507,050	$ 3,626,413
Loss from operations	(35,631)	(2,507,050)	(3,626,413)
Other income
Change in fair value of derivative warrant liabilities	(1,167,750)	3,602,500	11,549,160
Financing costs - derivative warrant liabilities	(433,190)
Net gain on investments held in Trust Account	617	3,218	19,250
Total other income (loss)	(1,600,323)	3,605,718	11,568,410
Net income (loss)	(1,635,954)	1,098,668	7,941,997
Class A ordinary shares
Other income
Net income (loss)	$ (723,074)	$ 878,934	$ 6,353,598
Basic and diluted weighted average shares outstanding	4,545,455	25,000,000	25,000,000
Basic and diluted net (loss) income per share	$ (0.16)	$ 0.04	$ 0.25
Class B ordinary shares
Other income
Net income (loss)	$ (912,880)	$ 219,734	$ 1,588,399
Basic and diluted weighted average shares outstanding	5,738,636	6,250,000	6,250,000
Basic and diluted net (loss) income per share	$ (0.16)	$ 0.04	$ 0.25

Unaudited Condensed Statements

Unaudited Condensed Statements of Changes in Shareholders' Deficit - USD ($)	Total	Common Class A [Member]	Common Class B [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Beginning balance at Aug. 04, 2020	$ 0	$ 0	$ 0	$ 0	$ 0
Beginning balance (Shares) at Aug. 04, 2020		0	0
Issuance of Class B ordinary shares to Sponsor	25,000		$ 647	24,353
Issuance of Class B ordinary shares to Sponsor (Shares)			6,468,750
Forfeiture of Class B ordinary shares from Sponsor			$ 22	22
Forfeiture of Class B ordinary shares from Sponsor (Shares)			(218,750)
Excess of cash receipts over the fair value of the private warrants sold to Sponsor	1,460,440			1,460,440
Accrection on Class A ordinary shares subject to possible redemption	(21,269,019)			(1,484,815)	(19,784,204)
Net income (loss)	(1,635,954)	$ (723,074)	$ (912,880)		(1,635,954)
Ending Balance at Sep. 30, 2020	(21,419,533)	$ 0	$ 625	0	(21,420,158)
Ending Balance (Shares) at Sep. 30, 2020		0	6,250,000
Beginning balance at Dec. 31, 2020	(29,071,814)	$ 0	$ 625	0	(29,072,439)
Beginning balance (Shares) at Dec. 31, 2020		0	6,250,000
Net income (loss)	7,069,017	$ 7,069,017	$ 7,069,017		7,069,017
Ending Balance at Mar. 31, 2021	(22,002,797)	$ 0	$ 625	0	(22,003,422)
Ending Balance (Shares) at Mar. 31, 2021		0	6,250,000
Beginning balance at Dec. 31, 2020	(29,071,814)	$ 0	$ 625	0	(29,072,439)
Beginning balance (Shares) at Dec. 31, 2020		0	6,250,000
Net income (loss)		$ 6,843,329
Ending Balance at Jun. 30, 2021	(22,228,485)	$ 0	$ 625	0	(22,229,110)
Ending Balance (Shares) at Jun. 30, 2021		0	6,250,000
Beginning balance at Dec. 31, 2020	(29,071,814)	$ 0	$ 625	0	(29,072,439)
Beginning balance (Shares) at Dec. 31, 2020		0	6,250,000
Accrection on Class A ordinary shares subject to possible redemption		$ (21,286,019)
Net income (loss)	7,941,997	6,353,598	$ 1,588,399
Ending Balance at Sep. 30, 2021	(21,129,817)	$ 0	$ 625	0	(21,130,442)
Ending Balance (Shares) at Sep. 30, 2021		0	6,250,000
Beginning balance at Mar. 31, 2021	(22,002,797)	$ 0	$ 625	0	(22,003,422)
Beginning balance (Shares) at Mar. 31, 2021		0	6,250,000
Net income (loss)	(225,688)	$ (225,688)	$ (225,688)		(225,688)
Ending Balance at Jun. 30, 2021	(22,228,485)	$ 0	$ 625	0	(22,229,110)
Ending Balance (Shares) at Jun. 30, 2021		0	6,250,000
Net income (loss)	1,098,668	$ 878,934	$ 219,734		1,098,668
Ending Balance at Sep. 30, 2021	$ (21,129,817)	$ 0	$ 625	$ 0	$ (21,130,442)
Ending Balance (Shares) at Sep. 30, 2021		0	6,250,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows	2 Months Ended	9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2021USD ($)
Cash Flows from Operating Activities:
Net income (loss)	$ (1,635,954)	$ 7,941,997
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Net gain on investments held in Trust Account	(617)	(19,250)
Change in fair value of derivative warrant liabilities	1,167,750	(11,549,160)
Financing costs - derivative warrant liabilities	433,190
General and administrative expenses paid by related party under note payable	26,961
Changes in operating assets and liabilities:
Prepaid expenses	(292,850)	91,782
Accounts payable	296,520	78,723
Accrued expenses		3,004,012
Accrued expenses - related party	5,000	152,892
Net cash used in operating activities	0	(299,004)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account		25,000
Cash deposited in Trust Account	(250,000,000)
Net cash provided by (used in) investing activities	(250,000,000)	25,000
Cash Flows from Financing Activities:
Proceeds received from initial public offering, gross	250,000,000
Proceeds received from private placement	7,000,000
Offering costs paid	(5,000,000)	(85,000)
Net cash (used in) provided by financing activities	252,000,000	(85,000)
Net change in cash	2,000,000	(359,004)
Cash - beginning of the period	0	1,277,714
Cash - end of the period	2,000,000	918,710
Supplemental disclosure of noncash investing and financing activities:
Offering costs included in accounts payable	139,550
Offering costs included in accrued expenses	334,860
Offering costs included in note payable - related party	92,198
Forfeiture of Class B ordinary shares from Sponsor	22
Deferred legal fees	100,000
Deferred underwriting commissions	8,750,000	8,750,000
Common Class B [Member]
Cash Flows from Operating Activities:
Net income (loss)	(912,880)	$ 1,588,399
Supplemental disclosure of noncash investing and financing activities:
Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	$ 25,000

Description of Organization, Bu

Description of Organization, Business Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2021
Description Of Organization Business Operations And Basis Of Presentation [Abstract]
Description of Organization, Business Operations and Basis of Presentation	Note 1—Description of Organization, Business Operations and Basis of Presentation Oaktree Acquisition Corp. II (the “Company”) was incorporated as a Cayman Islands exempted company on August 5, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganiz a As of September 30, 2021, the Company had not commenced any operations. All activity for the period from August 5, 2020 (inception) through September 30, 2021 relates to the Company’s formation, the initial public offering described below and since the closing of the initial public offering, the search for a prospective initial business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating The Company’s sponsor is Oaktree Acquisition Holdings II, L.P., a Cayman Islands exempted limited partnership (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on September 16, 2020. On September 21, 2020, the Company consummated its Initial Public Offering of 25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 2,500,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $250.0 million, and incurring offering costs of approximately $14.5 million, inclusive of approximately $8.8 million in deferred underwriting commissions (Note 5). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 4,666,667 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of $7.0 million (Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $250.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (net of amounts previously disbursed to management for Regulatory Withdrawals (as defined below) and excluding the amount of deferred underwriting discounts held in Trust and taxes payable on the income earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders (the “Public Shareholders”) of the Public Shares with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share non-public Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the amended and restated memorandum and articles of association (a) that would modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, or September 21, 2022 (the “Combination Period”) or (b) with respect to any other provision relating to shareholders’ rights or pre-initial If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share The Sponsor agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or members of the Company’s management team acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for serv i Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A, 1 3 Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Going Concern As of September 30, 2021, the Company had approximately $919,000 in its operating bank account and negative working capital of approximately $2.5 million. The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, the loan of approximately $119,000 from the Sponsor pursuant to the Expense Reimbursement Agreement (see Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. To date, the loan remains outstanding. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). As of September 30, 2021, there were no amounts outstanding under any Working Capital Loan. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate, September 21, 2022. These unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Summary of Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2—Summary of Significant Accounting Policies (as restated) Restatement of Previously Reported Financial Statements In preparation of the Company’s unaudited condensed financial statements for the quarterly period ended September 30, 2021, the Company concluded it should restate its previously issued financial statements to classify all Public Shares in temporary equity. In accordance with ASC 480-10-S99, redemption provisions not solely within the control of the Company, require shares subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of its Public Shares in permanent equity. Although the Company did not specify a maximum redemption threshold, its charter currently provides that the Company will not redeem its Public Shares in an amount that would cause its net tangible assets to be less than Previously, the Company did not consider redeemable shares classified as temporary equity as part of net tangible assets. Effective with these unaudited condensed financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. In accordance with SEC Staff Accounting Bulletin 10-Qs The impact of the restatement on the financial statements for the Affected Quarterly Peri o The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of March 31, 2021: As of March 31, 2021 (unaudited) As Reported Adjustment As Restated Total assets $ 251,368,069 $ 251,368,069 Total liabilities $ 23,370,865 $ 23,370,865 Class A ordinary shares subject to possible redemption $ 222,997,200 27,002,800 $ 250,000,000 Preference shares — — — Class A ordinary shares 270 (270 ) — Class B ordinary shares 625 — 625 Additional paid-in 7,201,327 (7,201,327 ) — Accumulated deficit (2,202,218 ) (19,801,203 ) (22,003,421 ) Total shareholders’ equity (deficit) $ 5,000,004 $ (27,002,800 ) $ (22,002,796 ) Total Liabilities, Class A Ordinary Shares Subject to Possible $ 251,368,069 $ — $ 251,368,069 Class A ordinary shares subject to redemption 22,299,720 2,700,280 25,000,000 Class A ordinary shares 2,700,280 (2,700,280 ) — The Company’s statement of shareholders’ equity has been restated to reflect the changes to the impacted shareholders’ equity accounts described above. The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the three months ended March 31, 2021: Form 10-Q As Reported Adjustment As Restated Supplemental Disclosure of Noncash Financing Activities: Change in value of Class A ordinary shares subject to possible redemption $ 7,069,020 $ (7,069,020 ) $ — The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of June 30, 2021: As of June 30, 2021 (unaudited) As Reported Adjustment As Restated Total assets $ 251,181,784 $ 251,181,784 Total liabilities $ 23,410,268 $ 23,410,268 Class A ordinary shares subject to possible redemption $ 222,771,510 27,228,490 $ 250,000,000 Preference shares — — — Class A ordinary shares 272 (272 ) — Class B ordinary shares 625 — 625 Additional paid-in 7,427,015 (7,427,015 ) — Accumulated deficit (2,427,906 ) (19,801,203 ) (22,229,109 ) Total shareholders’ equity (deficit) $ 5,000,006 $ (27,228,490 ) $ (22,228,484 ) Total Liabilities, Class A Ordinary Shares Subject to Possible $ 251,181,784 $ — $ 251,181,784 Class A ordinary shares subject to redemption 22,277,151 2,722,849 25,000,000 Class A ordinary shares 2,722,849 (2,722,849 ) — The Company’s statement of shareholders’ equity has been restated to reflect the changes to the impacted shareholders’ equity accounts described above. The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the six months ended June 30, 2021: Form 10-Q As Reported Adjustment As Restated Supplemental Disclosure of Noncash Financing Activities: Change in value of Class A ordinary shares subject to possible redemption $ 6,843,330 $ (6,843,330 ) $ — In connection with the change in presentation for the Public Shares, the Company has revised its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of shares participate pro rata in the income and losses of the Company. The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per common share is presented below for the Affected Quarterly Periods: Earnings Per Share for Class A ordinary shares As Reported Adjustment As Adjusted Form 10-Q 1 Net income $ 7,069,017 $ — $ 7,069,017 Weighted average shares outstanding 25,000,000 — 25,000,000 Basic and diluted earnings per share $ 0.00 $ 0.23 $ 0.23 Form 10-Q 1 Net loss $ (225,688 ) $ — $ (225,688 ) Weighted average shares outstanding 25,000,000 — 25,000,000 Basic and diluted loss per share $ 0.00 $ (0.01 ) $ (0.01 ) Form 10-Q 1 Net income $ 6,843,329 $ — $ 6,843,329 Weighted average shares outstanding 25,000,000 — 25,000,000 Basic and diluted earnings per share $ 0.00 $ 0.22 $ 0.22 Earnings Per Share for Class B ordinary shares As Reported Adjustment As Adjusted Form 10-Q 1 Net income $ 7,069,017 $ — $ 7,069,017 Weighted average shares outstanding 6,250,000 — 6,250,000 Basic and diluted earnings per share $ 1.13 $ (0.90 ) $ 0.23 Form 10-Q 1 Net loss $ (225,688 ) $ — $ (225,688 ) Weighted average shares outstanding 6,250,000 — 6,250,000 Basic and diluted loss per share $ (0.04 ) $ 0.03 $ (0.01 ) Form 10-Q 1 Net income $ 6,843,329 $ — $ 6,843,329 Weighted average shares outstanding 6,250,000 — 6,250,000 Basic and diluted earnings per share $ 1.09 $ (0.87 ) $ 0.22 Use of Estimates The preparation of these unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at September 30, 2021 or December 30, 2020. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in unrealized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Account. As of September 30, 2021 and December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. Fair Value Measurements The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets other than quoted prices included within Level 1 that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to remeasurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statement of operations. The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially measured at fair value using a Monte Carlo simulation model. The fair value of warrants issued in connection with our Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The subsequent fair value estimates of the Private Placement Warrants are measured using a combination of a Monte Carlo simulation model and the listed public warrant price. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the condensed statements of operations. Offering costs associated with issuance of the Class A ordinary shares were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with ASC 480. Class A ordinary shares subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within th e are Effective with the closing of the Initial Public Offering, the Company recognized the Income Taxes FASB ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) Per Ordinary Share The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 10,916,667, of the Company’s Class A ordinary shares in the calculation of diluted net income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2021. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of ordinary share: For the Three Months Ended For the Nine Months Ended Class A Class B Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 878,934 $ 219,734 $ 6,353,598 $ 1,588,399 Denominator: Basic and diluted weighted average ordinary shares outstanding 25,000,000 6,250,000 25,000,000 6,250,000 Basic and diluted net income per ordinary share $ 0.04 $ 0.04 $ 0.25 $ 0.25 For The Period Class A Class B Basic and diluted net loss per ordinary Numerator: Allocation of net loss $ (723,074 ) $ (912,880 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 4,545,455 5,738,636 Basic and diluted net loss per ordinary $ (0.16 ) $ (0.16 ) Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt—Debt (Subtopic 470-20) and (Subtopic 815-40): Accounting Equity” (“ASU 2020-06”), which ASU 2020-06 on The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncement if currently adopted would have a material effect on the Company’s unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Sep. 30, 2021
Initial Public Offering [Abstract]
Initial Public Offering	Note 3—Initial Public Offering On September 21, 2020, the Company consummated its Initial Public Offering of 25,000,000 Units, including 2,500,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $250.0 million, and incurring offering costs of approximately $14.5 million, inclusive of approximately $8.8 million in deferred underwriting commissions. Each Unit consisted of one Class A ordinary share, and one-fourth see Note 7

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 4—Related Party Transactions Founder Shares On August 7, 2020, the Sponsor paid $25,000 to cover certain expenses on behalf of the Company in exchange for issuance of 6,468,750 Class B ordinary shares, par value $0.0001, (the “Founder Shares”). The Sponsor agreed to forfeit up to 843,750 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On September 21, 2020, the underwriters partially exercised the over-allotment option to purchase 2,500,000 Over-Allotment Units; thus, an aggregate of 218,750 Founder Shares were forfeited accordingly. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Expense Reimbursement Agreement On August 7, 2020, the Sponsor agreed pursuant to an expense reimbursement agreement (“Expense Reimbursement Agreement”) to advance the Company up to $300,000 to pay for a portion of the expenses in connection with the Initial Public Offering. As of September 30, 2021 and s Working Capital Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2021, the Company had no borrowings under the Working Capital Loans. Administrative Support Agreement Commencing on the date the Company’s securities were first listed on the New York Stock Exchange, the Company agreed to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to the Company. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred $30,000 and $90,000 in expenses in connection with such services during the three and nine months ended September 30, 2021 as reflected in the accompanying unaudited condensed statement of operations. As of September 30, 2021 and December 31, 2020, the Company had and $35,000, respectively, in accrued expenses—related party in connection with such services as reflected in the accompanying unaudited condensed balance sheets.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments & Contingencies	Note 5—Commitments and Contingencies Registration and Shareholder Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration and shareholder rights agreement. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up Underwriting Agreement The Company granted the underwriters a 45-day The underwriters were entitled to an underwriting discount of $0.20 per unit, or $5.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $8.8 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Deferred Legal Fees The Company entered into an engagement letter to obtain legal advisory services, pursuant to which the Company’s legal counsel agreed to defer an aggregate of $100,000 of their fees in connection with the Initial Public Offering until the closing of the Initial Business Combination. The deferred fee will become payable to the legal counsel from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination. As of September 30, 2021 and December 31, 2020, the Company recorded an aggregate of fe s. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	9 Months Ended
	Sep. 30, 2021
Temporary Equity Disclosure [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	Note 6 — Class A Ordinary Shares Subject to Possible Redemption T e Com As of September 30, 2021 and December 31, 2020, there were Class A ordinary shares outstanding, all of which were subject to possible redemption. The Class A ordinary shares issued in the Initial Public Offering, including those issued as part of the Over-Allotment Units were recognized in Class A ordinary shares subject to possible redemption as follows: Gross Proceeds $ 250,000,000 Less: Offering costs allocated to Class A shares subject to possible redemption (14,025,419 ) Proceeds allocated to Public Warrants at issuance (7,260,600 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 21,286,019 Class A ordinary shares subject to possible redemption $ 250,000,000

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Note 7—Shareholders’ Equity Class A Ordinary Shares Holders of the Company’s Class A ordinary share are entitled to one vote foreach share. As of September 30, 2021 and December 31, 2020, there were Class A ordinary shares issued and outstanding, respectively, all of which are subject to possible redemption have been classified as temporary equity (see Note 6). Class B Ordinary Shares Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of our shareholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of our initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted Preference Shares o

Derivative Warrant Liabilities

Derivative Warrant Liabilities	9 Months Ended
	Sep. 30, 2021
Derivative Warrant Liabilities [Abstract]
Derivative Warrant Liabilities	Note 8—Derivative Warrant Liabilities As of September 30, 2021 and December 31, 2020, the Company has 6,250,000 and 4,666,667 Public Warrants and Private Placement Warrants, respectively, outstanding. Public Warrants may only be exercised for a whole number of shares. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per whole share, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company and, (i) in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance, and (ii) to the extent that such issuance is made to the Company or its affiliates, without taking into account the transfer of Founder Shares or Private Placement Warrants (including if such transfer is effectuated as a surrender to the Company and subsequent reissuance by the Company) by the Sponsor in connection with such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described below under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading The Company will not redeem the warrants unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day Redemption of Warrants when the price per Class A ordinary share equals or exceeds $10.00. Once the warrants become exercisable, we may redeem the outstanding warrants: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares; • if, and only if, the reported closing price of Class A ordinary shares equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and • if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading The “fair market value” of the Class A ordinary shares for the above purpose r 0.361 If the Company has not completed the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 8—Fair Value Measurements The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. September 30, 2021 Description Quoted Prices Significant Significant Assets: Investments held in Trust Account $ 250,001,168 $ — $ — Liabilities: Derivative warrant liabilities-public warrants $ 5,625,000 $ — $ — Derivative warrant liabilities-private warrants $ — $ 4,200,000 $ — December 31, 2020 Description Quoted Prices Significant Significant Assets: Investments held in Trust Account $ 250,006,919 $ — $ — Liabilities: Derivative warrant liabilities-public warrants $ 11,946,640 $ — $ — Derivative warrant liabilities-private warrants $ — $ — $ 9,427,520 Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. The private warrants were transferred from a Level 3 measurement to a Level 2 measurement in April 2021 as the private warrants are viewed as economically equivalent to the public warrants. Level 1 assets include investments in mutual funds and U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a combination of a Monte Carlo simulation model and the Public Warrant prices each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have been measured based on the listed market price of such warrants, a Level 1 measurement, since November 2020. For the nine months ended September 30, 2021, the Company recognized a condensed gain in the statements of operations resulting from a decrease in the fair value of liabilities of approximately million presented as change in fair value of derivative warrant liabilities on the accompanying condensed Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: As of Stock price $ 10.49 Volatility 24.5 % Expected life of the options to convert 6.21 Risk-free rate 0.54 % Dividend yield — The change in the fair value of the level 3 derivative warrant liabilities for the three and nine months ended September 30, 2021 is summarized as follows: Derivative warrant liabilities at December 31, 2020 $ 9,427,520 Change in fair value of derivative warrant liabilities (3,490,580 ) Derivative warrant liabilities at March 31, 2021 5,936,940 Transfer of private warrants to Level 2 (5,740,000 ) Change in fair value of derivative warrant liabilities (196,940 ) Derivative warrant liabilities at June 30, 2021 — Change in fair value of derivative warrant liabilities — Derivative warrant liabilities at September 30, 2021 $ — The Private Placement Warrants were classified as level 2 during the six months ended June 30, 2021 and there was no change in fair value of level 3 derivatives for the three months ended September 30, 2021.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 9—Subsequent Events Management has evaluated subsequent events to determine if events or transactions occurring through November 15

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Summary of Accounting Policies [Abstract]
Revision to Previously Reported Financial Statements	Restatement of Previously Reported Financial Statements In preparation of the Company’s unaudited condensed financial statements for the quarterly period ended September 30, 2021, the Company concluded it should restate its previously issued financial statements to classify all Public Shares in temporary equity. In accordance with ASC 480-10-S99, redemption provisions not solely within the control of the Company, require shares subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of its Public Shares in permanent equity. Although the Company did not specify a maximum redemption threshold, its charter currently provides that the Company will not redeem its Public Shares in an amount that would cause its net tangible assets to be less than Previously, the Company did not consider redeemable shares classified as temporary equity as part of net tangible assets. Effective with these unaudited condensed financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. In accordance with SEC Staff Accounting Bulletin 10-Qs The impact of the restatement on the financial statements for the Affected Quarterly Peri o The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of March 31, 2021: As of March 31, 2021 (unaudited) As Reported Adjustment As Restated Total assets $ 251,368,069 $ 251,368,069 Total liabilities $ 23,370,865 $ 23,370,865 Class A ordinary shares subject to possible redemption $ 222,997,200 27,002,800 $ 250,000,000 Preference shares — — — Class A ordinary shares 270 (270 ) — Class B ordinary shares 625 — 625 Additional paid-in 7,201,327 (7,201,327 ) — Accumulated deficit (2,202,218 ) (19,801,203 ) (22,003,421 ) Total shareholders’ equity (deficit) $ 5,000,004 $ (27,002,800 ) $ (22,002,796 ) Total Liabilities, Class A Ordinary Shares Subject to Possible $ 251,368,069 $ — $ 251,368,069 Class A ordinary shares subject to redemption 22,299,720 2,700,280 25,000,000 Class A ordinary shares 2,700,280 (2,700,280 ) — The Company’s statement of shareholders’ equity has been restated to reflect the changes to the impacted shareholders’ equity accounts described above. The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the three months ended March 31, 2021: Form 10-Q As Reported Adjustment As Restated Supplemental Disclosure of Noncash Financing Activities: Change in value of Class A ordinary shares subject to possible redemption $ 7,069,020 $ (7,069,020 ) $ — The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of June 30, 2021: As of June 30, 2021 (unaudited) As Reported Adjustment As Restated Total assets $ 251,181,784 $ 251,181,784 Total liabilities $ 23,410,268 $ 23,410,268 Class A ordinary shares subject to possible redemption $ 222,771,510 27,228,490 $ 250,000,000 Preference shares — — — Class A ordinary shares 272 (272 ) — Class B ordinary shares 625 — 625 Additional paid-in 7,427,015 (7,427,015 ) — Accumulated deficit (2,427,906 ) (19,801,203 ) (22,229,109 ) Total shareholders’ equity (deficit) $ 5,000,006 $ (27,228,490 ) $ (22,228,484 ) Total Liabilities, Class A Ordinary Shares Subject to Possible $ 251,181,784 $ — $ 251,181,784 Class A ordinary shares subject to redemption 22,277,151 2,722,849 25,000,000 Class A ordinary shares 2,722,849 (2,722,849 ) — The Company’s statement of shareholders’ equity has been restated to reflect the changes to the impacted shareholders’ equity accounts described above. The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the six months ended June 30, 2021: Form 10-Q As Reported Adjustment As Restated Supplemental Disclosure of Noncash Financing Activities: Change in value of Class A ordinary shares subject to possible redemption $ 6,843,330 $ (6,843,330 ) $ — In connection with the change in presentation for the Public Shares, the Company has revised its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of shares participate pro rata in the income and losses of the Company. The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per common share is presented below for the Affected Quarterly Periods: Earnings Per Share for Class A ordinary shares As Reported Adjustment As Adjusted Form 10-Q 1 Net income $ 7,069,017 $ — $ 7,069,017 Weighted average shares outstanding 25,000,000 — 25,000,000 Basic and diluted earnings per share $ 0.00 $ 0.23 $ 0.23 Form 10-Q 1 Net loss $ (225,688 ) $ — $ (225,688 ) Weighted average shares outstanding 25,000,000 — 25,000,000 Basic and diluted loss per share $ 0.00 $ (0.01 ) $ (0.01 ) Form 10-Q 1 Net income $ 6,843,329 $ — $ 6,843,329 Weighted average shares outstanding 25,000,000 — 25,000,000 Basic and diluted earnings per share $ 0.00 $ 0.22 $ 0.22 Earnings Per Share for Class B ordinary shares As Reported Adjustment As Adjusted Form 10-Q 1 Net income $ 7,069,017 $ — $ 7,069,017 Weighted average shares outstanding 6,250,000 — 6,250,000 Basic and diluted earnings per share $ 1.13 $ (0.90 ) $ 0.23 Form 10-Q 1 Net loss $ (225,688 ) $ — $ (225,688 ) Weighted average shares outstanding 6,250,000 — 6,250,000 Basic and diluted loss per share $ (0.04 ) $ 0.03 $ (0.01 ) Form 10-Q 1 Net income $ 6,843,329 $ — $ 6,843,329 Weighted average shares outstanding 6,250,000 — 6,250,000 Basic and diluted earnings per share $ 1.09 $ (0.87 ) $ 0.22
Use of Estimates	Use of Estimates The preparation of these unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at September 30, 2021 or December 30, 2020.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in unrealized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Account. As of September 30, 2021 and December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
Fair Value Measurements	Fair Value Measurements The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets other than quoted prices included within Level 1 that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to remeasurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s unaudited condensed statement of operations. The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially measured at fair value using a Monte Carlo simulation model. The fair value of warrants issued in connection with our Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The subsequent fair value estimates of the Private Placement Warrants are measured using a combination of a Monte Carlo simulation model and the listed public warrant price.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating expenses in the condensed statements of operations. Offering costs associated with issuance of the Class A ordinary shares were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with ASC 480. Class A ordinary shares subject to mandatory redemption (if any) is classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within th e are Effective with the closing of the Initial Public Offering, the Company recognized the
Income Taxes	Income Taxes FASB ASC Topic 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) Per Ordinary Share	Net Income (Loss) Per Ordinary Share The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 10,916,667, of the Company’s Class A ordinary shares in the calculation of diluted net income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2021. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of ordinary share: For the Three Months Ended For the Nine Months Ended Class A Class B Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 878,934 $ 219,734 $ 6,353,598 $ 1,588,399 Denominator: Basic and diluted weighted average ordinary shares outstanding 25,000,000 6,250,000 25,000,000 6,250,000 Basic and diluted net income per ordinary share $ 0.04 $ 0.04 $ 0.25 $ 0.25 For The Period Class A Class B Basic and diluted net loss per ordinary Numerator: Allocation of net loss $ (723,074 ) $ (912,880 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 4,545,455 5,738,636 Basic and diluted net loss per ordinary $ (0.16 ) $ (0.16 )
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt—Debt (Subtopic 470-20) and (Subtopic 815-40): Accounting Equity” (“ASU 2020-06”), which ASU 2020-06 on The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncement if currently adopted would have a material effect on the Company’s unaudited condensed financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2021
Summary of Accounting Policies [Abstract]
Schedule of earnings per share basic and diluted	Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each class of ordinary share: For the Three Months Ended For the Nine Months Ended Class A Class B Class A Class B Basic and diluted net income per ordinary share: Numerator: Allocation of net income $ 878,934 $ 219,734 $ 6,353,598 $ 1,588,399 Denominator: Basic and diluted weighted average ordinary shares outstanding 25,000,000 6,250,000 25,000,000 6,250,000 Basic and diluted net income per ordinary share $ 0.04 $ 0.04 $ 0.25 $ 0.25 For The Period Class A Class B Basic and diluted net loss per ordinary Numerator: Allocation of net loss $ (723,074 ) $ (912,880 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 4,545,455 5,738,636 Basic and diluted net loss per ordinary $ (0.16 ) $ (0.16 )
Schedula The effect of the financial statement adjustments related to the restatement discussed above of the Company's previously reported balance sheet	The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of March 31, 2021: As of March 31, 2021 (unaudited) As Reported Adjustment As Restated Total assets $ 251,368,069 $ 251,368,069 Total liabilities $ 23,370,865 $ 23,370,865 Class A ordinary shares subject to possible redemption $ 222,997,200 27,002,800 $ 250,000,000 Preference shares — — — Class A ordinary shares 270 (270 ) — Class B ordinary shares 625 — 625 Additional paid-in 7,201,327 (7,201,327 ) — Accumulated deficit (2,202,218 ) (19,801,203 ) (22,003,421 ) Total shareholders’ equity (deficit) $ 5,000,004 $ (27,002,800 ) $ (22,002,796 ) Total Liabilities, Class A Ordinary Shares Subject to Possible $ 251,368,069 $ — $ 251,368,069 Class A ordinary shares subject to redemption 22,299,720 2,700,280 25,000,000 Class A ordinary shares 2,700,280 (2,700,280 ) — The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the three months ended March 31, 2021: Form 10-Q As Reported Adjustment As Restated Supplemental Disclosure of Noncash Financing Activities: Change in value of Class A ordinary shares subject to possible redemption $ 7,069,020 $ (7,069,020 ) $ — The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of June 30, 2021: As of June 30, 2021 (unaudited) As Reported Adjustment As Restated Total assets $ 251,181,784 $ 251,181,784 Total liabilities $ 23,410,268 $ 23,410,268 Class A ordinary shares subject to possible redemption $ 222,771,510 27,228,490 $ 250,000,000 Preference shares — — — Class A ordinary shares 272 (272 ) — Class B ordinary shares 625 — 625 Additional paid-in 7,427,015 (7,427,015 ) — Accumulated deficit (2,427,906 ) (19,801,203 ) (22,229,109 ) Total shareholders’ equity (deficit) $ 5,000,006 $ (27,228,490 ) $ (22,228,484 ) Total Liabilities, Class A Ordinary Shares Subject to Possible $ 251,181,784 $ — $ 251,181,784 Class A ordinary shares subject to redemption 22,277,151 2,722,849 25,000,000 Class A ordinary shares 2,722,849 (2,722,849 ) — The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the six months ended June 30, 2021: Form 10-Q As Reported Adjustment As Restated Supplemental Disclosure of Noncash Financing Activities: Change in value of Class A ordinary shares subject to possible redemption $ 6,843,330 $ (6,843,330 ) $ —
Schedule The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per common share is presented	The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per common share is presented below for the Affected Quarterly Periods: Earnings Per Share for Class A ordinary shares As Reported Adjustment As Adjusted Form 10-Q 1 Net income $ 7,069,017 $ — $ 7,069,017 Weighted average shares outstanding 25,000,000 — 25,000,000 Basic and diluted earnings per share $ 0.00 $ 0.23 $ 0.23 Form 10-Q 1 Net loss $ (225,688 ) $ — $ (225,688 ) Weighted average shares outstanding 25,000,000 — 25,000,000 Basic and diluted loss per share $ 0.00 $ (0.01 ) $ (0.01 ) Form 10-Q 1 Net income $ 6,843,329 $ — $ 6,843,329 Weighted average shares outstanding 25,000,000 — 25,000,000 Basic and diluted earnings per share $ 0.00 $ 0.22 $ 0.22 Earnings Per Share for Class B ordinary shares As Reported Adjustment As Adjusted Form 10-Q 1 Net income $ 7,069,017 $ — $ 7,069,017 Weighted average shares outstanding 6,250,000 — 6,250,000 Basic and diluted earnings per share $ 1.13 $ (0.90 ) $ 0.23 Form 10-Q 1 Net loss $ (225,688 ) $ — $ (225,688 ) Weighted average shares outstanding 6,250,000 — 6,250,000 Basic and diluted loss per share $ (0.04 ) $ 0.03 $ (0.01 ) Form 10-Q 1 Net income $ 6,843,329 $ — $ 6,843,329 Weighted average shares outstanding 6,250,000 — 6,250,000 Basic and diluted earnings per share $ 1.09 $ (0.87 ) $ 0.22

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	9 Months Ended
	Sep. 30, 2021
Temporary Equity Disclosure [Abstract]
Schedule of Reconciliation of Class A ordinary shares subject to possible redemption	The Class A ordinary shares issued in the Initial Public Offering, including those issued as part of the Over-Allotment Units were recognized in Class A ordinary shares subject to possible redemption as follows: Gross Proceeds $ 250,000,000 Less: Offering costs allocated to Class A shares subject to possible redemption (14,025,419 ) Proceeds allocated to Public Warrants at issuance (7,260,600 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 21,286,019 Class A ordinary shares subject to possible redemption $ 250,000,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of fair value assets measured on recurring basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. September 30, 2021 Description Quoted Prices Significant Significant Assets: Investments held in Trust Account $ 250,001,168 $ — $ — Liabilities: Derivative warrant liabilities-public warrants $ 5,625,000 $ — $ — Derivative warrant liabilities-private warrants $ — $ 4,200,000 $ — December 31, 2020 Description Quoted Prices Significant Significant Assets: Investments held in Trust Account $ 250,006,919 $ — $ — Liabilities: Derivative warrant liabilities-public warrants $ 11,946,640 $ — $ — Derivative warrant liabilities-private warrants $ — $ — $ 9,427,520
Summary of quantitative information regarding Level 3 fair value measurements inputs	The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: As of Stock price $ 10.49 Volatility 24.5 % Expected life of the options to convert 6.21 Risk-free rate 0.54 % Dividend yield —
Summary of change in the fair value of the derivative warrant liabilities	The change in the fair value of the level 3 derivative warrant liabilities for the three and nine months ended September 30, 2021 is summarized as follows: Derivative warrant liabilities at December 31, 2020 $ 9,427,520 Change in fair value of derivative warrant liabilities (3,490,580 ) Derivative warrant liabilities at March 31, 2021 5,936,940 Transfer of private warrants to Level 2 (5,740,000 ) Change in fair value of derivative warrant liabilities (196,940 ) Derivative warrant liabilities at June 30, 2021 — Change in fair value of derivative warrant liabilities — Derivative warrant liabilities at September 30, 2021 $ —

Description of Organization, _2

Description of Organization, Business Operations and Basis of Presentation - Additional Information (Detail) - USD ($)	Sep. 21, 2020	Sep. 30, 2021	Dec. 31, 2020
Initial public offer, offering cost	$ 14,500,000
Initial public offer, share price			$ 10.49
Securities maturity period		185 days
Business combination conditions		The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (net of amounts previously disbursed to management for Regulatory Withdrawals (as defined below) and excluding the amount of deferred underwriting discounts held in Trust and taxes payable on the income earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
Temporary equity redemption price per share		$ 10
Business combination covenant terms		In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination.
Description of results for non compliance with business combination		The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the amended and restated memorandum and articles of association (a) that would modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, or September 21, 2022
Working capital		$ 2.5
Receipts from capital contributions by sponsors		25,000
Due to related parties current		119,000
Cash		919,000
Working capital loan		0
Maximum regulatory withdrawal		250,000
Common Class A [Member]
Proceeds from issuance initial public offering		$ 250,000,000
Temporary equity redemption price per share		$ 10
Maximum [Member]
Dissolution expense		$ 100,000
Private Placement [Member]
Warrants issued		4,666,667
Warrants prices		$ 1.50
Proceeds from issuance of private placement warrants		$ 7,000,000
IPO [Member]
Initial public offer, shares issued	25,000,000
Proceeds from issuance initial public offering	$ 250,000,000
Initial public offer, share price		$ 10
Proceeds from issuance of private placement warrants		$ 250,000,000
Percentage of temporary equity redemption		15.00%
IPO [Member] | Common Class A [Member]
Sale of stock issue price per share	$ 10
Over-Allotment Option [Member]
Initial public offer, shares issued	2,500,000
Deferred underwriting commission	$ 8,800,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (as restated) - Schedule the effect of the financial statement adjustments related to the restatement discussed above of the Company's previously reported balance sheet (Details) - USD ($)	3 Months Ended	6 Months Ended
	Mar. 31, 2021	Jun. 30, 2021	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Aug. 04, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total assets			$ 251,077,485	$ 251,534,022
Total liabilities			22,207,302	30,605,836
Class A ordinary shares subject to possible redemption			250,000,000	250,000,000
Preference shares			0	0
Additional paid-in capital			0	0
Accumulated deficit			(21,130,442)	(29,072,439)
Total shareholders' equity	$ (22,002,797)	$ (22,228,485)	(21,129,817)	(29,071,814)	$ (21,419,533)	$ 0
Total Liabilities, Class A ordinary shares subject to possible redemption, and Shareholders' Deficit			251,077,485	251,534,022
Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total assets	251,368,069	251,181,784
Total liabilities	23,370,865	23,410,268
Class A ordinary shares subject to possible redemption	22,299,720	22,277,151
Preference shares	0	0
Ordinary shares	2,700,280	2,722,849
Additional paid-in capital	7,201,327	7,427,015
Accumulated deficit	(2,202,218)	(2,427,906)
Total shareholders' equity	5,000,004	5,000,006
Total Liabilities, Class A ordinary shares subject to possible redemption, and Shareholders' Deficit	251,368,069	251,181,784
Change in value of Class A ordinary shares subject to possible redemption	7,069,020	6,843,330
Restatement Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to possible redemption	2,700,280	2,722,849
Preference shares	0	0
Ordinary shares	(2,700,280)	(2,722,849)
Additional paid-in capital	(7,201,327)	(7,427,015)
Accumulated deficit	(19,801,203)	(19,801,203)
Total shareholders' equity	(27,002,800)	(27,228,490)
Total Liabilities, Class A ordinary shares subject to possible redemption, and Shareholders' Deficit	0	0
Change in value of Class A ordinary shares subject to possible redemption	(7,069,020)	(6,843,330)
As restated [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total assets	251,368,069	251,181,784
Total liabilities	23,370,865	23,410,268
Class A ordinary shares subject to possible redemption	25,000,000	25,000,000
Preference shares	0	0
Ordinary shares	0	0
Additional paid-in capital	0	0
Accumulated deficit	(22,003,421)	(22,229,109)
Total shareholders' equity	(22,002,796)	(22,228,484)
Total Liabilities, Class A ordinary shares subject to possible redemption, and Shareholders' Deficit	251,368,069	251,181,784
Change in value of Class A ordinary shares subject to possible redemption	0	0
Common Class A [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to possible redemption			250,000,000
Ordinary shares			0	0
Total shareholders' equity	0	0	0	0	0	0
Common Class A [Member] | Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to possible redemption	222,997,200	222,771,510
Ordinary shares	270	272
Common Class A [Member] | Restatement Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to possible redemption	27,002,800	27,228,490
Ordinary shares	(270)	(272)
Common Class A [Member] | As restated [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to possible redemption	250,000,000	250,000,000
Ordinary shares	0	0
Common Class B [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares	625		625	625
Total shareholders' equity	625	625	$ 625	$ 625	$ 625	$ 0
Common Class B [Member] | Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares	625	625
Common Class B [Member] | Restatement Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares	$ 0	0
Common Class B [Member] | As restated [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ordinary shares		$ 625

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (as restated) - Schedule The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per common share is presented (Details) - USD ($)	2 Months Ended	3 Months Ended			6 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2021
Error Corrections And Prior Period Adjustments Of Supplemental Disclosure Of Noncash Financing Activities Restatement [Line Items]
Net income (loss)	$ (1,635,954)	$ 1,098,668	$ (225,688)	$ 7,069,017			$ 7,941,997
Common Class A [Member]
Error Corrections And Prior Period Adjustments Of Supplemental Disclosure Of Noncash Financing Activities Restatement [Line Items]
Net income (loss)	$ (723,074)	$ 878,934	$ (225,688)	$ 7,069,017	$ 6,843,329		$ 6,353,598
Basic and diluted weighted average shares outstanding	4,545,455	25,000,000	25,000,000	25,000,000	25,000,000		25,000,000
Basic and diluted net (loss) income per share	$ (0.16)	$ 0.04	$ (0.01)	$ 0.23	$ 0.22		$ 0.25
Common Class B [Member]
Error Corrections And Prior Period Adjustments Of Supplemental Disclosure Of Noncash Financing Activities Restatement [Line Items]
Net income (loss)	$ (912,880)	$ 219,734	$ (225,688)	$ 7,069,017		$ 6,843,329	$ 1,588,399
Basic and diluted weighted average shares outstanding	5,738,636	6,250,000	6,250,000	6,250,000		6,250,000	6,250,000
Basic and diluted net (loss) income per share	$ (0.16)	$ 0.04	$ (0.01)	$ 0.23		$ 0.22	$ 0.25
Previously Reported [Member] | Common Class A [Member]
Error Corrections And Prior Period Adjustments Of Supplemental Disclosure Of Noncash Financing Activities Restatement [Line Items]
Net income (loss)			$ (225,688)	$ 7,069,017	$ 6,843,329
Basic and diluted weighted average shares outstanding			25,000,000	25,000,000	25,000,000
Basic and diluted net (loss) income per share			$ 0	$ 0	$ 0
Previously Reported [Member] | Common Class B [Member]
Error Corrections And Prior Period Adjustments Of Supplemental Disclosure Of Noncash Financing Activities Restatement [Line Items]
Net income (loss)			$ (225,688)	$ 7,069,017		$ 6,843,329
Basic and diluted weighted average shares outstanding			6,250,000	6,250,000		6,250,000
Basic and diluted net (loss) income per share			$ (0.04)	$ 1.13		$ 1.09
Restatement Adjustment [Member] | Common Class A [Member]
Error Corrections And Prior Period Adjustments Of Supplemental Disclosure Of Noncash Financing Activities Restatement [Line Items]
Net income (loss)			$ 0	$ 0	$ 0
Basic and diluted weighted average shares outstanding				0	0
Basic and diluted net (loss) income per share			$ (0.01)	$ 0.23	$ 0.22
Restatement Adjustment [Member] | Common Class B [Member]
Error Corrections And Prior Period Adjustments Of Supplemental Disclosure Of Noncash Financing Activities Restatement [Line Items]
Net income (loss)			$ 0	$ 0		$ 0
Basic and diluted weighted average shares outstanding			0	0		0
Basic and diluted net (loss) income per share			$ 0.03	$ (0.90)		$ (0.87)

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Federal deposit insurance coverage amount	$ 250,000
Previously Reported [Member]
Threshold Net Tangible assets required to be maintained for compliance	$ 5,000,001
Common Class A [Member]
Temporary shares outstanding	25,000,000	25,000,000
Common Stock [Member]
Antidilutive securities	10,916,667

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Schedule Of Earnings Per Share Basic and Diluted (Detail) - USD ($)	2 Months Ended	3 Months Ended			6 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2021
Numerator:
Allocation of net income	$ (1,635,954)	$ 1,098,668	$ (225,688)	$ 7,069,017			$ 7,941,997
Common Class A [Member]
Numerator:
Allocation of net income	$ (723,074)	$ 878,934	$ (225,688)	$ 7,069,017	$ 6,843,329		$ 6,353,598
Denominator:
Basic and diluted weighted average ordinary shares outstanding	4,545,455	25,000,000	25,000,000	25,000,000	25,000,000		25,000,000
Basic and diluted net income per ordinary share	$ (0.16)	$ 0.04	$ (0.01)	$ 0.23	$ 0.22		$ 0.25
Common Class B [Member]
Numerator:
Allocation of net income	$ (912,880)	$ 219,734	$ (225,688)	$ 7,069,017		$ 6,843,329	$ 1,588,399
Denominator:
Basic and diluted weighted average ordinary shares outstanding	5,738,636	6,250,000	6,250,000	6,250,000		6,250,000	6,250,000
Basic and diluted net income per ordinary share	$ (0.16)	$ 0.04	$ (0.01)	$ 0.23		$ 0.22	$ 0.25

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($)	Sep. 21, 2020	Sep. 30, 2020	Sep. 30, 2021
Proceeds from capital units issuance		$ 250,000,000
Class of warrants exercise price			$ 11.50
Over-Allotment Option [Member]
Capital units issued	2,500,000
Capital units price per share	$ 10
Proceeds from capital units issuance	$ 250,000,000
Offering cost of capital units	14,500,000
Deferred underwriting commission	$ 8,800,000
IPO [Member]
Capital units issued	25,000,000
Common Class A [Member]
Class of warrants exercise price	$ 11.50		$ 11.50

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Sep. 21, 2020	Aug. 07, 2020	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2020
Related party transaction expense		$ 25,000		$ 10,000
Percentage of founder shares on outstanding shares		20.00%
Common stock shares resale or transfer share price threshold				$ 12
Class of warrants redemption exercise price			$ 11.50	$ 11.50
Advances from related party agreed amount		$ 300,000
Due to related parties current			$ 119,000	$ 119,000
Expense Reimbursement Agreement [Member]
Due to related parties current			119,000	119,000	$ 119,000
Administrative Support Agreement [Member]
Related party transaction expense			30,000	90,000
Accrued expenses—related party			125,000	$ 125,000	$ 35,000
Private Placement [Member]
Warrants issued				4,666,667
Warrants prices				$ 1.50
Proceeds from issuance of private placement warrants				$ 7,000,000
Working capital loans eligible for conversion into warrants			$ 1,500,000	$ 1,500,000
Warrant conversion price				$ 1.50
Over-Allotment Option [Member]
Founder shares subject to forfeited over-allotment	218,750
Options exercised to purchase number of units	2,500,000
Common Class A [Member]
Common stock par value			$ 0.0001	0.0001	$ 0.0001
Class of warrants redemption exercise price	$ 11.50		$ 11.50	$ 11.50
Common Class B [Member]
Common stock, shares outstanding		6,468,750	6,250,000	6,250,000	6,250,000
Common stock par value		$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Maximum [Member]
Founder shares subject to redemption		843,750

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	Sep. 21, 2020	Sep. 21, 2020	Sep. 30, 2021	Dec. 31, 2020
Statements [Line Items]
Deferred legal fees			$ 100,000	$ 100,000
Legal fees payable			$ 100,000
Over-Allotment Option [Member]
Statements [Line Items]
Options available to purchase	3,375,000
Capital Units Issued	2,500,000
Underwriting discount per unit	$ 0.20	$ 0.20
Underwriting income loss		$ 5,000,000
Deferred Underwriting Commission	$ 8,800,000
Over-Allotment Option [Member] | Additional [Member]
Statements [Line Items]
Underwriting discount per unit	$ 0.35	$ 0.35
Deferred Underwriting Commission		$ 8,800,000

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Detail) - Common Class A [Member] - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Temporary Equity [Line Items]
Temporary equity shares authorized	300,000,000
Temporary equity, par or stated value per share	$ 0.0001	$ 0.0001
Temporary equity shares outstanding	25,000,000	25,000,000

Class A Ordinary Shares Subje_4

Class A Ordinary Shares Subject to Possible Redemption - Schedule of Reconciliation of Class A Ordinary Shares Subject to Possible Redemption (Detail) - USD ($)	2 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Temporary Equity [Line Items]
Accretion on Class A ordinary shares subject to possible redemption amount	$ 21,269,019
Class A ordinary shares subject to possible redemption		$ 250,000,000	$ 250,000,000
Common Class A [Member]
Temporary Equity [Line Items]
Gross Proceeds		250,000,000
Offering costs allocated to Class A shares subject to possible redemption		(14,025,419)
Proceeds allocated to Public Warrants at issuance		(7,260,600)
Accretion on Class A ordinary shares subject to possible redemption amount		21,286,019
Class A ordinary shares subject to possible redemption		$ 250,000,000

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Detail)	Sep. 21, 2020shares	Sep. 30, 2021Vote$ / sharesshares	Dec. 31, 2020$ / sharesshares	Aug. 07, 2020$ / sharesshares
Common stock conversion description		20% of the sum of (i) the total number of Class A ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of Working Capital Loans.
Preferred shares authorized		1,000,000	1,000,000
Preferred stock par value | $ / shares		$ 0.0001	$ 0.0001
Common stock conversion description		20% of the sum of (i) the total number of Class A ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of Working Capital Loans.
Over-Allotment Option [Member]
Options exercised to purchase number of units	2,500,000
Common Class A [Member]
Common stock shares authorized		300,000,000	300,000,000
Common stock par value | $ / shares		$ 0.0001	$ 0.0001
Common stock shares		25,000,000	25,000,000
Temporary Equity Outstanding		25,000,000	25,000,000
Number of votes per share | Vote		1
Common Class B [Member]
Common stock shares authorized		30,000,000	30,000,000
Common stock par value | $ / shares		$ 0.0001	$ 0.0001	$ 0.0001
Common stock shares		6,250,000	6,250,000	6,468,750
Common Shares Outstanding		6,250,000	6,250,000	6,468,750
Common Stock, Shares,subject to forfeiture				843,750
Percent of stock owned				20.00%
Common Class B [Member] | Over-Allotment Option [Member]
Common Stock, Shares,subject to forfeiture	218,750

Derivative Warrant Liabilities

Derivative Warrant Liabilities - Additional Information (Details)	9 Months Ended
	Sep. 30, 2021$ / sharesshares	Dec. 31, 2020shares	Sep. 21, 2020$ / shares
Derivative Warrant Liabilities [Line Items]
Class of warrants exercise price	$ 11.50
Warrants and Rights Outstanding, Term	5 years
Percent of gross proceeds	60.00%
Ratio of redemption feature per warrant	36.1
Triggering Share Price Of Common Stock Class A [Member]
Derivative Warrant Liabilities [Line Items]
Business acquisition, share price	$ 9.20
Private Placement Warrants [Member]
Derivative Warrant Liabilities [Line Items]
Warrant or Right, Outstanding | shares		4,666,667
Private Placement Warrants [Member] | Share trigger price one [Member]
Derivative Warrant Liabilities [Line Items]
Warrants redemption price per share	$ 0.01
Minimum notice period for warrants redemption	30 days
Private Placement Warrants [Member] | Share trigger price one [Member] | Maximum [Member]
Derivative Warrant Liabilities [Line Items]
Class of warrants exercise price adjustment percentage	115.00%
Warrants redeemable threshold consecutive trading days	30 days
Private Placement Warrants [Member] | Share trigger price one [Member] | Minimum [Member]
Derivative Warrant Liabilities [Line Items]
Warrants redeemable threshold consecutive trading days	20 days
Private Placement Warrants [Member] | Share trigger price two [Member]
Derivative Warrant Liabilities [Line Items]
Warrants redemption price per share	$ 0.10
Minimum notice period for warrants redemption	30 days
Private Placement Warrants [Member] | Share trigger price two [Member] | Maximum [Member]
Derivative Warrant Liabilities [Line Items]
Class of warrants exercise price adjustment percentage	180.00%
Warrants redeemable threshold consecutive trading days	30 days
Private Placement Warrants [Member] | Share trigger price two [Member] | Minimum [Member]
Derivative Warrant Liabilities [Line Items]
Warrants redeemable threshold consecutive trading days	20 days
Public Warrants [Member]
Derivative Warrant Liabilities [Line Items]
Warrant or Right, Outstanding | shares	6,250,000	6,250,000
Common Class A [Member]
Derivative Warrant Liabilities [Line Items]
Class of warrants exercise price	$ 11.50		$ 11.50
Shares Issued, Price Per Share	$ 9.20
Common Class A [Member] | Share trigger price one [Member] | Minimum [Member]
Derivative Warrant Liabilities [Line Items]
Warrants redeemable threshold consecutive trading days	30 days
Common Class A [Member] | Share trigger price two [Member] | Maximum [Member]
Derivative Warrant Liabilities [Line Items]
Warrants redeemable threshold consecutive trading days	10 days
Common Class A [Member] | Private Placement Warrants [Member] | Share trigger price one [Member]
Derivative Warrant Liabilities [Line Items]
Warrants redemption price per share	$ 18
Common Class A [Member] | Private Placement Warrants [Member] | Share trigger price two [Member]
Derivative Warrant Liabilities [Line Items]
Warrants redemption price per share	$ 10
Private Placement [Member]
Derivative Warrant Liabilities [Line Items]
Warrant or Right, Outstanding | shares	4,666,667

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Fair Value Assets Measured On Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative warrant liabilities-public warrants	$ 5,625,000	$ 11,946,640
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative warrant liabilities-private warrants	4,200,000
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative warrant liabilities-private warrants		9,427,520
Assets Held In Trust [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments held in Trust Account	$ 250,001,168	$ 250,006,919

Fair value Measurements - Summa

Fair value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs (Detail)	3 Months Ended	12 Months Ended
	Dec. 31, 2020$ / shares	Dec. 31, 2020$ / shares
Fair value Measurements [Abstract]
Stock price	$ 10.49	$ 10.49
Volatility	24.50%
Expected life of the options to convert	6 years 2 months 15 days
Risk-free rate	0.54%
Dividend yield

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Change In The Fair Value Of The Derivative Warrant Liabilities (Detail) - USD ($)	2 Months Ended	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2021
Fair Value Measurements [Line Items]
Change in fair value of derivative warrant liabilities	$ (1,167,750)	$ 3,602,500			$ 11,549,160
Level 3 [Member]
Fair Value Measurements [Line Items]
Derivative warrant liabilities at Begining Balance			$ 5,936,940	$ 9,427,520	9,427,520
Change in fair value of derivative warrant liabilities		0	(196,940)	(3,490,580)
Transfer of private warrants to Level 2			(5,740,000)
Derivative warrant liabilities at Ending Balance		$ 0		$ 5,936,940	$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) $ in Millions	9 Months Ended
	Sep. 30, 2021USD ($)
Change In Fair Value Of Derivative Warrant Liabilities [Member]
Change in fair value of derivative warrant liabilities	$ 11.5